Meeting Banner
Abstract #3633

Potential Utility of Early Post-Operative Diffusion-Weighted Imaging and Perfusion Weighted Imaging in Differentiating Between Pseudo-Progression and Progression in Patients with Glioblastoma Treated with Temozolomide and Radiotherapy

Xiang Liu1, Wei Tian1, Henry Wang1, Sven Ekholm1

1Imaging Science, University of Rochester Medical Center, Rochester, NY, United States

Standard chemo-radiation therapy with temozolomide may induce pseudo-progression in 20-50% patients with glioblastomas, which resembles true tumor progression on conventional MRI. We reviewed sequential MRI examinations in 41 patients with new diagnosed glioblastoma, our preliminary result showed that increased rCBV value in the early post-operative PWI examinations may be useful in differentiating pseudoprogression and tumor progression in such patients within 6 months after radiation/ temozolomide treatment. Early post-operative restricted diffusion has limited potential value in distinguishing pseudo-progression from tumor progression

Abstract PDF

Keywords

addition alone among apparent arrow artifacts blood blue cavity cerebral coefficient concurrent contrast criteria decreased detected determine diagnosed differentiate differentiating difficult diffusion distinguished dynamic early enhancement evaluated examinations excluded finally findings gold henry hours included indicates induce initial injuries limited literatures materials medical month months moths neurology newly nine novel operation operative patients perfusion post postoperative potential preliminary previous progress progression prone protocol proved pseudo radiation radiotherapy reduced regimen reported represented resection restricted science sequential subsequently suggest susceptibility transfer treated treatment true tumor unacceptable useful utility visually volume